AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28532509 — intervention group
Group type: COMPARATOR
Intervention: Standard dialysis temperature of 36.5 °C
Number of subjects: 18
Study 25869467 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotic and steroid combination (ofloxacin 0.26% and dexamethasone 0.053% nasal drops) for 10 days, administered intranasally (5 drops in each nostril/8 hours)
Number of subjects: 40
Study 25869467 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotic alone (amoxicillin 90 mg/kg)
Number of subjects: 40
Study 23261786 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month-olds; identical music and room on test day to learning environment
Number of subjects: 0
Study 23261786 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month-olds; change in music allowed
Number of subjects: 0
Study 23261786 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month-olds; change in room and music allowed
Number of subjects: 0
Study 21612429 — intervention group
Group type: EXPERIMENTAL
Intervention: Guarana 50 mg by mouth twice daily
Number of subjects: 75
Study 21612429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 19824119 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal butorphanol (n = 30)
Number of subjects: 60
Study 19824119 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular meperidine (n = 30)
Number of subjects: 60
Study 16805714 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological agents
Number of subjects: 0
Study 16805714 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination regimens with chemotherapy and/or biological therapy
Number of subjects: 0
Study 16805714 — intervention group
Group type: COMPARATOR
Intervention: Cytotoxic chemotherapy
Number of subjects: 0
Study 15541858 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonabsorbable sutures (group A)
Number of subjects: 60
Study 15541858 — intervention group
Group type: COMPARATOR
Intervention: Prolene mesh (group B)
Number of subjects: 60
Study 11391692 — intervention group
Group type: EXPERIMENTAL
Intervention: General method for generating new distributions with an intensity function
Number of subjects: 0
Study 11391692 — intervention group
Group type: EXPERIMENTAL
Intervention: Families of distributions based on the Pareto distribution
Number of subjects: 0
Study 11391692 — intervention group
Group type: EXPERIMENTAL
Intervention: Updating procedures similar to Kalman filter
Number of subjects: 0
Study 11391692 — intervention group
Group type: EXPERIMENTAL
Intervention: Updating procedures similar to copulas
Number of subjects: 0
Study 9602319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear Ferning Test (TFT) performed at enrollment and after 1 month (T1)
Number of subjects: 116
Study 9602319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear Ferning Test (TFT) considering only type I ferning
Number of subjects: 116
Study 8167785 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration treatment
Number of subjects: 6
Study 8167785 — intervention group
Group type: COMPARATOR
Intervention: Placebo/control treatment
Number of subjects: 6
Study 2964981 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 21
Study 2964981 — intervention group
Group type: COMPARATOR
Intervention: Intensified conventional treatment (ICT) using the NovoPen
Number of subjects: 21
Study 2964981 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire results
Number of subjects: 21
Study 30301187 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus vaccination with Audencel (weekly intranodal application in weeks 7 to 10, followed by monthly intervals)
Number of subjects: 76
Study 30301187 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus vaccination with Audencel
Number of subjects: 76
Study 30301187 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 76
Study 26879587 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (20 IU twice daily)
Number of subjects: 28
Study 26879587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 28
Study 25867659 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical and nutritional rehabilitation plus information delivered during the post-ICU hospital stay by dedicated rehabilitation assistants.
Number of subjects: 240
Study 25867659 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 240
Study 25867659 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical and nutritional rehabilitation plus information provision (intervention group).
Number of subjects: 240
Study 23993440 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent exercise
Number of subjects: 0
Study 23993440 — intervention group
Group type: EXPERIMENTAL
Intervention: Less frequent exercise
Number of subjects: 0
Study 20573800 — intervention group
Group type: EXPERIMENTAL
Intervention: Atkins
Number of subjects: 291
Study 20573800 — intervention group
Group type: EXPERIMENTAL
Intervention: LEARN
Number of subjects: 291
Study 20573800 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornish
Number of subjects: 291
Study 20573800 — intervention group
Group type: EXPERIMENTAL
Intervention: Zone
Number of subjects: 291
Study 18637156 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg of imidafenacin/day
Number of subjects: 401
Study 18637156 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg of imidafenacin/day
Number of subjects: 401
Study 18637156 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of imidafenacin/day
Number of subjects: 401
Study 18637156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study 17436825 — intervention group
Group type: EXPERIMENTAL
Intervention: ER-minocycline 1 mg/kg
Number of subjects: 233
Study 17436825 — intervention group
Group type: EXPERIMENTAL
Intervention: ER-minocycline 2 mg/kg
Number of subjects: 233
Study 17436825 — intervention group
Group type: EXPERIMENTAL
Intervention: ER-minocycline 3 mg/kg
Number of subjects: 233
Study 17436825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study 14601274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutured technique of catheter fixation
Number of subjects: 50
Study 14601274 — intervention group
Group type: COMPARATOR
Intervention: Tunnelled technique
Number of subjects: 50
Study 10992826 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 14
Study 10992826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 10992826 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 14
Study 8798927 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of tramadol (Protradon and Tramal)
Number of subjects: 12
Study 1335441 — intervention group
Group type: EXPERIMENTAL
Intervention: GU‐052 (3 x 4 g daily)
Number of subjects: 40
Study 1335441 — intervention group
Group type: COMPARATOR
Intervention: Glucotard (3 x 5 g daily)
Number of subjects: 40
Study 6693703 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacists prescribing drug therapy
Number of subjects: 0
Study 6693703 — intervention group
Group type: COMPARATOR
Intervention: Traditional patient care (Control)
Number of subjects: 0
Study 31962317 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid (0.3%, pH 3.2) for 300 s
Number of subjects: 40
Study 31962317 — intervention group
Group type: COMPARATOR
Intervention: Hydrochloric acid (0.01 M, pH 2.38) for 300 s
Number of subjects: 40
Study 31962317 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid (0.3%, pH 3.2) for 30 s
Number of subjects: 40
Study 31962317 — intervention group
Group type: COMPARATOR
Intervention: Hydrochloric acid (0.01 M, pH 2.38) for 30 s
Number of subjects: 40
Study 31367875 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling with care coordination (CCC)
Number of subjects: 606
Study 31367875 — intervention group
Group type: COMPARATOR
Intervention: Counseling only (C)
Number of subjects: 606
Study 29170440 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue-inducing hand-grip task for 10 minutes
Number of subjects: 0
Study 29170440 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing the target image
Number of subjects: 0
Study 29170440 — intervention group
Group type: COMPARATOR
Intervention: Control images
Number of subjects: 0
Study 27043327 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring (TM)
Number of subjects: 111
Study 27043327 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 111
Study 24679469 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 10 mg
Number of subjects: 24
Study 24679469 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 30 mg
Number of subjects: 24
Study 24679469 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 24
Study 24679469 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 300 mg
Number of subjects: 24
Study 24679469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 24679469 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab (combined doses)
Number of subjects: 24
Study 24679469 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 24
Study 21889833 — intervention group
Group type: EXPERIMENTAL
Intervention: 62 mg tramadol ODT
Number of subjects: 604
Study 21889833 — intervention group
Group type: EXPERIMENTAL
Intervention: 89 mg tramadol ODT
Number of subjects: 604
Study 21889833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 604
Study 19178747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training (three sessions per week on a cycle ergometer for six months)
Number of subjects: 72
Study 19178747 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise training (walking program to achieve the same weekly physical activity for six months)
Number of subjects: 72
Study 19178747 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study 17184435 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental 5 mg x kg(‐1) i.v. for children up to 3 years; 2.5 mg x kg(‐1) i.v. rescue boluses if needed.
Number of subjects: 38
Study 17184435 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1-1.5 mg x kg(‐1) i.v. for children over 3 years; maintained with 0.1-0.15 mg x kg(‐1) x min(‐1) continuous i.v. infusion, increased if needed.
Number of subjects: 38
Study 15184692 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity (1 SD unit change)
Number of subjects: 4594
Study 15184692 — intervention group
Group type: COMPARATOR
Intervention: Control for confounding variables (sex, socioeconomic status, smoking, alcohol consumption, health, appearance, achievement)
Number of subjects: 4594
Study 11300446 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin (0.4 mg/d)
Number of subjects: 37
Study 11300446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 9394873 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 4016
Study 9394873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4016
Study 9394873 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic Antidepressant (TCA)
Number of subjects: 4016
Study 8288357 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional wood and canvas stretcher
Number of subjects: 60
Study 3501482 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular stimulation (MS)
Number of subjects: 10
Study 3501482 — intervention group
Group type: COMPARATOR
Intervention: No muscular stimulation (Control)
Number of subjects: 10
Study 27977223 — intervention group
Group type: EXPERIMENTAL
Intervention: ERRT with nightmare exposure and rescripting (full protocol; EX)
Number of subjects: 70
Study 27977223 — intervention group
Group type: COMPARATOR
Intervention: ERRT without nightmare exposure and rescripting (NEX)
Number of subjects: 70
Study 27388364 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycaemic index (GI) diet
Number of subjects: 169
Study 27388364 — intervention group
Group type: COMPARATOR
Intervention: High-cereal fibre diet
Number of subjects: 169
Study 24625229 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioengineered hyaluronic acid (BioHA, 1% sodium hyaluronate) intra-articular injections
Number of subjects: 214
Study 24625229 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioengineered hyaluronic acid (BioHA)
Number of subjects: 214
Study 24625229 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (CC) including NSAIDs and analgesics
Number of subjects: 214
Study 23422634 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid collars (TCs) used during cephalometric radiography
Number of subjects: 100
Study 23422634 — intervention group
Group type: COMPARATOR
Intervention: No thyroid collars (NTC) used during cephalometric radiography
Number of subjects: 100
Study 20214822 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated three layer straight tubular bandaging system (3L)
Number of subjects: 0
Study 20214822 — intervention group
Group type: COMPARATOR
Intervention: Standard short stretch compression bandaging system (SS)
Number of subjects: 0
Study 18456565 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 25
Study 18456565 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructans
Number of subjects: 25
Study 18456565 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of fructose and fructans
Number of subjects: 25
Study 18456565 — intervention group
Group type: COMPARATOR
Intervention: Glucose (Control)
Number of subjects: 25
Study 15706200 — intervention group
Group type: EXPERIMENTAL
Intervention: Art therapy intervention
Number of subjects: 83
Study 15706200 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital services
Number of subjects: 83
Study 14565628 — intervention group
Group type: EXPERIMENTAL
Intervention: Flite Tabs (150 mg pinokinase)
Number of subjects: 204
Study 14565628 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 204
Study 11180192 — intervention group
Group type: EXPERIMENTAL
Intervention: CCmax (complete set of Cmax data including subjects with FCM)
Number of subjects: 0
Study 11180192 — intervention group
Group type: COMPARATOR
Intervention: TCmax (truncated set of data excluding subjects with FCM)
Number of subjects: 0
Study 8828022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine 10mg once daily in the morning
Number of subjects: 396
Study 8828022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine 20mg once daily in the morning
Number of subjects: 396
Study 8828022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine 10mg once daily in the evening
Number of subjects: 396
Study 8828022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 8828022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine 10mg or 20mg once daily (4-month study)
Number of subjects: 396
Study 8828022 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4-month study)
Number of subjects: 396
Study 1526683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime (CDZ) 2 g i.v. once daily for seven days
Number of subjects: 20
Study 1526683 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment (Control)
Number of subjects: 20
Study 6360688 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (D) 282 +/- 102 mg/day
Number of subjects: 70
Study 6360688 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (P) 158 +/- 81 mg/day
Number of subjects: 70
Study 30972793 — intervention group
Group type: EXPERIMENTAL
Intervention: Home OGTT device
Number of subjects: 100
Study 30972793 — intervention group
Group type: COMPARATOR
Intervention: Secondary analyser
Number of subjects: 100
Study 29338462 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 200
Study 29338462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 27016862 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized smoking cessation intervention (physician advice, nicotine replacement therapy, referral to counseling)
Number of subjects: 142
Study 27016862 — intervention group
Group type: COMPARATOR
Intervention: Usual care for smoking cessation
Number of subjects: 142
Study 24880226 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified high-intensity interval training (mHIT)
Number of subjects: 66
Study 24880226 — intervention group
Group type: COMPARATOR
Intervention: Usual healthcare (UC)
Number of subjects: 66
Study 22176806 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 51
Study 22176806 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 51
Study 19850697 — intervention group
Group type: EXPERIMENTAL
Intervention: Log-transformed urinary albumin-to-creatinine ratio
Number of subjects: 2131
Study 19850697 — intervention group
Group type: COMPARATOR
Intervention: Randomized treatments (n-3 polyunsaturated fatty acids or rosuvastatin)
Number of subjects: 2131
Study 18069598 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0
Study 18069598 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin AT1 receptor antagonists
Number of subjects: 0
Study 18069598 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 15858603 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathing with water only
Number of subjects: 73
Study 15858603 — intervention group
Group type: COMPARATOR
Intervention: Bathing with mild pH neutral soap and water
Number of subjects: 73
Study 12172536 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and behavioral characteristics (age ≤19 years, previous abortion, frequency of sexual encounters at least once a week, chlamydial infection)
Number of subjects: 877
Study 12172536 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 6 or more risk characteristics
Number of subjects: 877
Study 10023611 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic community treatment
Number of subjects: 46
Study 7788898 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel at 180 mg/kg bwt for three days
Number of subjects: 202
Study 7788898 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole at 90 mg/kg bwt for three days
Number of subjects: 202
Study 7788898 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel at 90 mg/kg bwt plus Albendazole at 45 mg/kg for three days
Number of subjects: 202
Study 1980930 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 20
Study 1980930 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 20
Study 7070229 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005 mg/kg of apomorphine
Number of subjects: 5
Study 7070229 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 5
Study 31248276 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeless individuals
Number of subjects: 547
Study 30036691 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) on acupuncture points Hegu and Zusanli
Number of subjects: 50
Study 30036691 — intervention group
Group type: COMPARATOR
Intervention: Sham group (placebo)
Number of subjects: 50
Study 30036691 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 50
Study 25947278 — intervention group
Group type: EXPERIMENTAL
Intervention: Axxess™ bifurcation stent and BioMatrix™ stents
Number of subjects: 40
Study 25947278 — intervention group
Group type: COMPARATOR
Intervention: Culotte technique using XIENCE™ stents
Number of subjects: 40
Study 25947278 — intervention group
Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 40
Study 24875890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 24875890 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg
Number of subjects: 90
Study 24875890 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 2 μg/kg
Number of subjects: 90
Study 24319306 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT) program, financial incentives ranging from zero to approximately 3-4 months wage
Number of subjects: 0
Study 19398463 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine (1 microg/kg every 4 hours)
Number of subjects: 80
Study 19398463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 19398463 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 17453612 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) - two 20-minute sessions
Number of subjects: 48
Study 17453612 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE) - one 15-minute session
Number of subjects: 48
Study 16443607 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 112
Study 12591004 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrox-coated ALA formulation (6g dose)
Number of subjects: 12
Study 12591004 — intervention group
Group type: COMPARATOR
Intervention: Non-coated ALA formulation (6g dose)
Number of subjects: 12
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual influenza vaccination
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled O2
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive‐pressure ventilation
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with beta‐agonist and anticholinergic bronchodilators
Number of subjects: 0
Study 11194781 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy
Number of subjects: 0
Study 8858633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative mitomycin-C (0.1 mg/ml applied for 3 minutes)
Number of subjects: 156